The Importance Of 'Agility' We couldn’t agree more with the 2020 Forbes Article describing Agility as the new superpower. Agility has allowed ApconiX to thrive and grow during the pandemic and to integrate new working practices into our future ways of working. So, what does agility mean for us? Primarily, it means [...]
ApconiX Welcomes Dr Sean Hammond ApconiX is delighted to welcome Dr Sean Hammond who joins us as an Immunotoxicology Lead and is the latest addition to our growing target safety assessment team. Sean recently completed his PhD at the University of Liverpool, following on from his first degree in [...]
ApconiX Welcomes Dr James Sidaway ApconiX is delighted to welcome Dr James Sidaway who joins us as Target Safety Assessment (TSA) Discipline Lead. The target safety assessment team is growing as the demand for our service continues to increase significantly. James (also known as Sid) is an experienced and [...]
ApconiX Is Recruiting an Expert Electrophysiologist ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. We are now looking to grow our team of [...]
We are recruiting an Admin & Finance Assistant (initially part time with flexible working options).ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a unique company. We are [...]
ApconiX is Recruiting a Target Safety Assessment Discipline Lead ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. We are now [...]
ApconiX Welcomes Simon Craige to the Team ApconiX is delighted to welcome Simon Craige to the team. Simon has over 15 years’ nonclinical and toxicology experience working in several medical and pharmaceutical organisations across multiple disciplines including small molecules, vaccines, biologics, and medical devices. He has experience of a [...]
ApconiX Welcomes Dr Duncan Armstrong ApconiX is delighted to welcome Dr Duncan Armstrong to the team. Duncan has expert knowledge in molecular pharmacology, preclinical safety pharmacology and secondary pharmacodynamics gained over 18 years working in drug discovery and development at AstraZeneca UK and Novartis USA. He has worked with [...]
ApconiX Welcomes Dr Laurence Bishop ApconiX is delighted to welcome Dr Laurence Bishop to the team as our Head of Business Development. Laurence is an experienced DMPK and toxicological scientist with 20 years’ experience of nonclinical drug development. Specialising in business development for the past 13 years, we are [...]
ApconiX Welcomes Dr Selvan Bavan ApconiX welcomes Dr Selvan Bavan, who joins us to carry out ion channel research using manual patch-clamp while learning more about using automated patch-clamp by working with Dr Michael Morton and Dr Karen Jones. Selvan commented, “Conventional manual patch-clamp is regarded as a ‘gold [...]
